publication date: Apr 25, 2017
|
author/source: Hichrom
A new application note demonstrating the high resolution separation of the monoclonal antibody trastuzumab has been published by Advanced Materials Technology (AMT). The separation is acheived in approximately 5 minutes at 80°C, under gradient conditions with UV detection.
Trastuzumab (MW ~148 kDa) is used to treat breast cancer. Enhanced resolution of trastuzumab and its variants is acheived using a new HALO 1000Å C4 column. HALO 1000Å C4 columns contain the world’s first 2.7 micron superficially porous silica particles with 1000Å pores. The pore size and structure of these particles enable molecules to achieve complete penetration of the porous structure, allowing enhanced interaction with more of the bonded surface for better retention and selectivity. This results in improved separations of these types of large molecules.
This application note and a technical brochure are available from Hichrom Limited and demonstrate the ability of HALO 1000Å C4 to provide valuable detailed information not possible to acheive when using particles with smaller pore sizes.
For more information or a copy of the technical brochure click here or email technical@hichrom.co.uk
more news from Hichrom
Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!
Request your free copies HERE
Popular this Month
Top 10 most popular articles this month
Today's Picks
Looking for a Supplier?
Search by company or by product
Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.
Lab Bulletin is published by newleaf marketing communications ltd.